NKMAX Co., Ltd. — Investor Relations & Filings
NKMAX Co., Ltd. is a biotechnology company focused on developing immune-based solutions centered on Natural Killer (NK) cells. The company's primary focus is the development of adoptive cell therapies to treat incurable diseases, including cancer, autoimmune disorders, and neurodegenerative conditions. Its portfolio includes anti-cancer immunotherapy treatments and other biological products. In addition to therapeutics, NKMAX develops and markets a precision diagnostic test that measures NK cell activity. The company also manufactures and supplies specialized reagents, such as high-quality recombinant proteins and antibodies, for biotechnology research, as well as a line of health functional foods designed to support the immune system.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 사외이사의선임ㆍ해임또는중도퇴임에관한신고 | 2024-04-08 | Korean | |
| 감사보고서제출 | 2024-04-05 | Korean | |
| 사업보고서 (2023.12) | 2024-04-05 | Korean | |
| 기타시장안내 (상장폐지 관련) | 2024-04-05 | Korean | |
| 주권매매거래정지기간변경 (상장폐지 사유 발생) | 2024-04-05 | Korean | |
| 기타시장안내 (상장적격성 실질심사 관련 절차 안내) | 2024-04-05 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 8149655 | 사외이사의선임ㆍ해임또는중도퇴임에관한신고 | 2024-04-08 | Korean | ||
| 8150135 | 감사보고서제출 | 2024-04-05 | Korean | ||
| 8149847 | 사업보고서 (2023.12) | 2024-04-05 | Korean | ||
| 8149832 | 기타시장안내 (상장폐지 관련) | 2024-04-05 | Korean | ||
| 8149831 | 주권매매거래정지기간변경 (상장폐지 사유 발생) | 2024-04-05 | Korean | ||
| 8149825 | 기타시장안내 (상장적격성 실질심사 관련 절차 안내) | 2024-04-05 | Korean | ||
| 8152283 | 정기주주총회결과 | 2024-03-29 | Korean | ||
| 8157674 | 주권매매거래정지 (상장적격성 실질심사 대상 (사유발생)) | 2024-03-25 | Korean | ||
| 8157672 | 불성실공시법인지정 (공시번복 1건, 공시불이행 4건) | 2024-03-25 | Korean | ||
| 8157622 | 기타시장안내 (상장적격성 실질심사 관련 안내) | 2024-03-25 | Korean | ||
| 8157573 | 기타시장안내 (상장적격성 실질심사 대상결정 기한 안내) | 2024-03-25 | Korean | ||
| 8163536 | 기타경영사항(자율공시) (감사보고서 지연 제출) | 2024-03-21 | Korean | ||
| 8162830 | 사업보고서제출기한연장신고서 (2023.12) | 2024-03-21 | Korean | ||
| 8181226 | [기재정정]주주총회소집공고 | 2024-03-15 | Korean | ||
| 8181795 | 주주총회소집공고 | 2024-03-14 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
NKMAX Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/17727/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=17727 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=17727 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=17727 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 17727}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for NKMAX Co., Ltd. (id: 17727)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.